Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure
- 1 December 1990
- journal article
- Published by Elsevier in Kidney International
- Vol. 38 (6) , 1164-1168
- https://doi.org/10.1038/ki.1990.328
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patientsKidney International, 1989
- Sekundärer Immundefekt bei Niereninsuffizienz am Beispiel der Hepatitis B-ImpfungJournal of Molecular Medicine, 1988
- Monocytes and MacrophagesNew England Journal of Medicine, 1988
- Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.Journal of Clinical Investigation, 1987
- Trivalent influenza vaccine in patients on haemodialysis: Impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine componentsVaccine, 1987
- Kinetic Analysis of Interleukin 2 (IL‐2) Production and Expression of IL‐2 Receptors by Uraemic and Normal LymphocytesScandinavian Journal of Immunology, 1987
- Hepatitis B Vaccine in Patients Receiving HemodialysisNew England Journal of Medicine, 1984
- Active hepatitis B vaccination of dialysis patients and medical staffKidney International, 1984
- The Biology of Interleukin-1 and Its Relevance to HemodialysisBlood Purification, 1983
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTSThe Lancet, 1981